SEROTONERGIC ANTAGONISTS AND VASCULAR-DISEASE

被引：20
作者：
VANHOUTTE, PM
机构：
[1] Baylor College of Medicine, Houston, TX
来源：
CARDIOVASCULAR DRUGS AND THERAPY | 1990年 / 4卷
关键词：
adrenergic nerves; atherosclerosis; endothelium; endothelium-derived contracting factor; endothelium-derived relaxing factor; hypertension; regenerated endothelium; serotonin;
D O I：
10.1007/BF00053420
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5-Hydroxytryptamine (serotonin) can evoke both contraction and relaxation of vascular smooth muscle. In disease, the constrictor component of the response to the monoamine appears to dominate. 5HT2-serotonergicantagonists favor dilatation, not only because they block the activating effect of serotonin on vascular smooth muscle, but also because they unmask the (endothelium-dependent) relaxation to the monoamine and brake the amplifying effect that it exerts on platelet aggregation. These properties of serotonergic antagonists help to explain their protective effects in vascular disease. © 1990 Kluwer Academic Publishers.
引用
收藏
页码：7 / 12
页数：6
相关论文
共 50 条
[11]   MODULATION OF VASOCONSTRICTION BY ENDOTHELIUM-DERIVED NITRIC-OXIDE - THE INFLUENCE OF VASCULAR-DISEASE [J].
WOODMAN, OL .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1995, 22 (09) :585-593
[12]   HYPERTENSION AND VASCULAR-DISEASE IN THE 1990S [J].
GORLIN, R .
CLINICAL CARDIOLOGY, 1991, 14 (08) :1-5
[13]   THE PREVALENCE OF PERIPHERAL VASCULAR-DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA [J].
KROON, AA ;
AJUBI, N ;
VANASTEN, WNJC ;
STALENHOEF, AFH .
JOURNAL OF INTERNAL MEDICINE, 1995, 238 (05) :451-459
[14]   LIPOPROTEIN(A) AND ITS ROLE IN OCCLUSIVE VASCULAR-DISEASE [J].
TENNANT, M ;
MCGEACHIE, JK .
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 1993, 75 (01) :3-7
[15]   NONINVASIVE PULSE-WAVE ANALYSIS FOR THE EARLY DETECTION OF VASCULAR-DISEASE [J].
COHN, JN ;
FINKELSTEIN, S ;
MCVEIGH, G ;
MORGAN, D ;
LEMAY, L ;
ROBINSON, J ;
MOCK, J .
HYPERTENSION, 1995, 26 (03) :503-508
[16]   MAGNETIC-RESONANCE-IMAGING OF ATHEROSCLEROTIC VASCULAR-DISEASE [J].
UNDERWOOD, SR ;
MOHIADDIN, RH .
AMERICAN JOURNAL OF HYPERTENSION, 1993, 6 (11) :S335-S339
[17]   HYPERHOMOCYSTEINEMIA AND THE RISK FOR VASCULAR-DISEASE IN HEMODIALYSIS-PATIENTS [J].
BACHMANN, J ;
TEPEL, M ;
RAIDT, H ;
RIEZLER, R ;
GRAEFE, U ;
LANGER, K ;
ZIDEK, W .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (01) :121-125
[18]   HYPERINSULINEMIA AS PREDICTOR OF ATHEROSCLEROTIC VASCULAR-DISEASE - EPIDEMIOLOGIC EVIDENCE [J].
PYORALA, K .
DIABETES & METABOLISM, 1991, 17 (1BIS) :87-92
[19]   VON-WILLEBRAND-FACTOR AND THE ENDOTHELIUM IN VASCULAR-DISEASE [J].
BLANN, A .
BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 1993, 50 (02) :125-134
[20]   RENAL VASCULAR-DISEASE IN PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID ANTIBODIES [J].
MANDREOLI, M ;
ZUCCHELLI, P .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1993, 8 (11) :1277-1280
12345